In Silico Analysis Highlights Potential Predictive Indicators Associated with Secondary Progressive Multiple Sclerosis
Multiple sclerosis (MS) is a complex inflammatory disease affecting the central nervous system. Most commonly, it begins with recurrent symptoms followed by partial or complete recovery, known as relapsing–remitting MS (RRMS). Over time, many RRMS patients progress to secondary progressive MS (SPMS)...
Main Authors: | Marco Calabrò, Maria Lui, Emanuela Mazzon, Simone D’Angiolini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/6/3374 |
Similar Items
-
New possibilities for the therapy of secondary progressive multiple sclerosis
by: A. M. Petrov, et al.
Published: (2019-12-01) -
A Comprehensive Exploration of the Transcriptomic Landscape in Multiple Sclerosis: A Systematic Review
by: Luigi Chiricosta, et al.
Published: (2023-01-01) -
Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis
by: Ya. V. Vlasov, et al.
Published: (2021-09-01) -
New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis
by: D. S. Kasatkin, et al.
Published: (2021-02-01) -
Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects»
by: N. V. Khachanova, et al.
Published: (2019-12-01)